Guangdong Dashenlin Chain Drugstore Co., Ltd., commonly referred to as Dashenlin, is a prominent player in the pharmaceutical retail industry, headquartered in Guangdong, China. Established in 1996, the company has expanded its operations across major regions in China, becoming a trusted name in healthcare and wellness. Dashenlin specialises in a wide range of products, including prescription medications, over-the-counter drugs, health supplements, and personal care items. What sets Dashenlin apart is its commitment to quality and customer service, ensuring that consumers have access to safe and effective healthcare solutions. With a strong market position, Dashenlin has achieved significant milestones, including numerous awards for excellence in retail pharmacy. The company continues to innovate and adapt to the evolving needs of the healthcare sector, solidifying its reputation as a leader in the industry.
How does Guangdong Dashenlin Chain Drugstore Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Guangdong Dashenlin Chain Drugstore Co., Ltd.'s score of 20 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Guangdong Dashenlin Chain Drugstore Co., Ltd., headquartered in China, currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any specific reduction targets or climate pledges, indicating a lack of formal commitments towards carbon neutrality or emissions reduction initiatives. As there is no emissions data or climate commitments available, it is essential to note that the company may still be operating within an industry context that increasingly prioritises sustainability and climate action. Many organisations in the retail and pharmaceutical sectors are adopting science-based targets and engaging in initiatives to reduce their carbon footprints. However, without specific data or commitments from Guangdong Dashenlin, it is unclear how they align with these industry trends.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Guangdong Dashenlin Chain Drugstore Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
